Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-4.18%
operating margin TTM
8.92%
revenue TTM
4.57 Billion
revenue per share TTM
9.82$
valuation ratios | |
|---|---|
| pe ratio | -18.78 |
| peg ratio | -0.40 |
| price to book ratio | -20.09 |
| price to sales ratio | 1.18 |
| enterprise value multiple | 6.74 |
| price fair value | -20.09 |
profitability ratios | |
|---|---|
| gross profit margin | 36.52% |
| operating profit margin | 8.92% |
| pretax profit margin | -1.97% |
| net profit margin | -4.18% |
| return on assets | -3.34% |
| return on equity | 144.35% |
| return on capital employed | 10.51% |
liquidity ratio | |
|---|---|
| current ratio | 1.41 |
| quick ratio | 0.86 |
| cash ratio | 0.10 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 126.05 |
| operating cycle | 227.39 |
| days of payables outstanding | 53.24 |
| cash conversion cycle | 174.15 |
| receivables turnover | 3.60 |
| payables turnover | 6.86 |
| inventory turnover | 2.90 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | -3.03 |
| long term debt to capitalization | -5.01 |
| total debt to capitalization | 1.49 |
| interest coverage | 0.96 |
| cash flow to debt ratio | 0.89 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.71 |
| cash per share | 0.36 |
| operating cash flow per share | 0.95 |
| free cash flow operating cash flow ratio | 0.75 |
| cash flow coverage ratios | 0.89 |
| short term coverage ratios | 1.23 |
| capital expenditure coverage ratio | 3.97 |
Frequently Asked Questions
When was the last time Amneal Pharmaceuticals, Inc. (NYSE:AMRX) reported earnings?
Amneal Pharmaceuticals, Inc. (AMRX) published its most recent earnings results on 12-11-2024.
What is Amneal Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Amneal Pharmaceuticals, Inc. (NYSE:AMRX)'s trailing twelve months ROE is 144.35%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Amneal Pharmaceuticals, Inc. (AMRX) currently has a ROA of -3.34%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AMRX's net profit margin stand at?
AMRX reported a profit margin of -4.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AMRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.41 in the most recent quarter. The quick ratio stood at 0.86, with a Debt/Eq ratio of -3.03.